PLEKHG7
gene geneOn this page
Also known as FLJ46688
Summary
PLEKHG7 (pleckstrin homology and RhoGEF domain containing G7, HGNC:33829) is a protein-coding gene on chromosome 12q22, encoding Pleckstrin homology domain-containing family G member 7 (Q6ZR37).
Predicted to enable guanyl-nucleotide exchange factor activity. Predicted to be involved in Rho protein signal transduction.
Source: NCBI Gene 440107 — RefSeq curated summary.
At a glance
- GWAS associations: 6
- Clinical variants (ClinVar): 64 total
- MANE Select transcript:
NM_001377329
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:33829 |
| Approved symbol | PLEKHG7 |
| Name | pleckstrin homology and RhoGEF domain containing G7 |
| Location | 12q22 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ46688 |
| Ensembl gene | ENSG00000187510 |
| Ensembl biotype | protein_coding |
| Entrez | 440107 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 6 protein_coding, 1 nonsense_mediated_decay
ENST00000344636, ENST00000397833, ENST00000544406, ENST00000549856, ENST00000647865, ENST00000898649, ENST00000898650
RefSeq mRNA: 3 — MANE Select: NM_001377329
NM_001037671, NM_001178097, NM_001377329
CCDS: CCDS41819, CCDS53818, CCDS91737
Canonical transcript exons
ENST00000344636 — 17 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001363878 | 92764041 | 92764194 |
| ENSE00001367929 | 92755825 | 92755940 |
| ENSE00001368162 | 92736482 | 92736577 |
| ENSE00001376087 | 92761752 | 92761831 |
| ENSE00001382936 | 92770088 | 92772455 |
| ENSE00001385251 | 92756298 | 92756391 |
| ENSE00001386333 | 92754090 | 92754264 |
| ENSE00001389724 | 92768983 | 92769080 |
| ENSE00001530410 | 92706471 | 92707138 |
| ENSE00002386565 | 92728993 | 92729120 |
| ENSE00002404210 | 92732233 | 92732273 |
| ENSE00003361463 | 92740853 | 92740948 |
| ENSE00003365295 | 92745478 | 92745591 |
| ENSE00003415441 | 92741491 | 92741592 |
| ENSE00003804649 | 92737378 | 92737521 |
| ENSE00003833174 | 92707650 | 92707672 |
| ENSE00003916193 | 92702989 | 92703132 |
Expression profiles
Bgee: expression breadth broad, 70 present calls, max score 85.09.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1439 / max 19.6882, expressed in 41 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 127337 | 0.0883 | 30 |
| 127336 | 0.0556 | 22 |
Top tissues by expression
214 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| olfactory segment of nasal mucosa | UBERON:0005386 | 85.09 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 84.38 | gold quality |
| right uterine tube | UBERON:0001302 | 82.57 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.89 | silver quality |
| sural nerve | UBERON:0015488 | 64.62 | gold quality |
| vermiform appendix | UBERON:0001154 | 62.78 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 62.44 | gold quality |
| lymph node | UBERON:0000029 | 61.02 | gold quality |
| bone marrow cell | CL:0002092 | 59.72 | silver quality |
| tibial nerve | UBERON:0001323 | 57.95 | gold quality |
| caecum | UBERON:0001153 | 57.86 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 56.34 | gold quality |
| right lung | UBERON:0002167 | 55.38 | gold quality |
| fallopian tube | UBERON:0003889 | 55.35 | gold quality |
| left uterine tube | UBERON:0001303 | 55.09 | gold quality |
| colonic epithelium | UBERON:0000397 | 54.99 | gold quality |
| gall bladder | UBERON:0002110 | 53.40 | gold quality |
| body of pancreas | UBERON:0001150 | 53.31 | gold quality |
| endometrium | UBERON:0001295 | 52.90 | gold quality |
| rectum | UBERON:0001052 | 52.40 | gold quality |
| spleen | UBERON:0002106 | 52.27 | gold quality |
| tonsil | UBERON:0002372 | 51.94 | gold quality |
| pancreas | UBERON:0001264 | 51.72 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 51.71 | gold quality |
| small intestine | UBERON:0002108 | 50.63 | gold quality |
| lower lobe of lung | UBERON:0008949 | 50.63 | silver quality |
| adult mammalian kidney | UBERON:0000082 | 49.57 | gold quality |
| islet of Langerhans | UBERON:0000006 | 49.49 | gold quality |
| right lobe of liver | UBERON:0001114 | 48.75 | gold quality |
| liver | UBERON:0002107 | 47.47 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 8.98 |
| E-MTAB-6678 | no | 2.41 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
86 targeting PLEKHG7, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-1252-5P | 100.00 | 69.80 | 2774 |
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-MIR-433-3P | 99.98 | 69.37 | 1203 |
| HSA-LET-7A-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7B-5P | 99.98 | 72.31 | 1790 |
| HSA-LET-7C-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7E-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7F-5P | 99.98 | 72.56 | 1784 |
| HSA-LET-7G-5P | 99.98 | 72.37 | 1784 |
| HSA-LET-7I-5P | 99.98 | 72.37 | 1788 |
| HSA-MIR-98-5P | 99.98 | 72.33 | 1787 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-548AT-5P | 99.96 | 70.83 | 2666 |
| HSA-LET-7D-5P | 99.96 | 71.76 | 1632 |
| HSA-MIR-4458 | 99.96 | 71.64 | 1650 |
| HSA-MIR-552-5P | 99.93 | 68.56 | 1583 |
| HSA-MIR-145-5P | 99.92 | 71.13 | 1836 |
| HSA-MIR-5195-3P | 99.92 | 70.92 | 1877 |
| HSA-MIR-5682 | 99.89 | 72.56 | 1005 |
| HSA-MIR-137-3P | 99.87 | 74.74 | 2401 |
| HSA-MIR-1323 | 99.83 | 69.89 | 2471 |
| HSA-MIR-6875-3P | 99.82 | 70.26 | 2983 |
| HSA-MIR-4659A-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4659B-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-548AJ-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-548F-5P | 99.78 | 71.02 | 3093 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | plekhg7 | ENSDARG00000062855 |
| caenorhabditis_elegans | WBGENE00006476 |
Paralogs (1): PLEKHG5 (ENSG00000171680)
Protein
Protein identifiers
Pleckstrin homology domain-containing family G member 7 — Q6ZR37 (reviewed: Q6ZR37)
All UniProt accessions (3): Q6ZR37, A0A3B3ISE0, R4GMP4
UniProt curated annotations — full annotation on UniProt →
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6ZR37-1 | 1 | yes |
| Q6ZR37-2 | 2 | |
| Q6ZR37-3 | 3 |
RefSeq proteins (3): NP_001032760, NP_001171568, NP_001364258* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000219 | DH_dom | Domain |
| IPR001849 | PH_domain | Domain |
| IPR011993 | PH-like_dom_sf | Homologous_superfamily |
| IPR035899 | DBL_dom_sf | Homologous_superfamily |
| IPR040181 | PKHG5/7 | Family |
Pfam: PF00621, PF15720
UniProt features (12 total): splice variant 4, domain 2, sequence variant 2, region of interest 2, chain 1, glycosylation site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6ZR37-F1 | 63.60 | 0.15 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (1): 395
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 52 (showing top):
chr12q22, GOMF_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY, GOMF_NUCLEOSIDE_TRIPHOSPHATASE_REGULATOR_ACTIVITY, GOMF_ENZYME_REGULATOR_ACTIVITY, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, HSF2_TARGET_GENES, ZNF92_TARGET_GENES, MIR8485, MIR3646, MIR4659A_3P_MIR4659B_3P, MIR513A_3P_MIR513C_3P, MIR511_5P, MIR519E_5P, MIR515_5P, MIR519D_5P
GO Biological Process (1): Rho protein signal transduction (GO:0007266)
GO Molecular Function (2): guanyl-nucleotide exchange factor activity (GO:0005085), protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| small GTPase-mediated signal transduction | 1 |
| GTP binding | 1 |
| GDP binding | 1 |
| GTPase regulator activity | 1 |
| binding | 1 |
Protein interactions and networks
STRING
306 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PLEKHG7 | TMEM213 | A2RRL7 | 478 |
| PLEKHG7 | ZNF485 | Q8NCK3 | 475 |
| PLEKHG7 | FER1L6 | Q2WGJ9 | 462 |
| PLEKHG7 | CLXN | Q9HAE3 | 460 |
| PLEKHG7 | ARHGEF33 | A8MVX0 | 460 |
| PLEKHG7 | KBTBD12 | Q3ZCT8 | 448 |
| PLEKHG7 | ARHGEF38 | Q9NXL2 | 438 |
| PLEKHG7 | RIMS2 | Q9UQ26 | 436 |
| PLEKHG7 | ZNF483 | Q8TF39 | 431 |
| PLEKHG7 | WDFY3 | Q8IZQ1 | 418 |
| PLEKHG7 | FAM184B | Q9ULE4 | 415 |
| PLEKHG7 | NXPH3 | O95157 | 412 |
| PLEKHG7 | LCORL | Q8N3X6 | 400 |
| PLEKHG7 | PLEKHG3 | A1L390 | 393 |
| PLEKHG7 | VPS4A | Q9UN37 | 371 |
IntAct
231 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PLEKHG7 | HTRA2 | psi-mi:“MI:0407”(direct interaction) | 0.590 |
| PRKAB2 | PLEKHG7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| AGXT | PLEKHG7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PLEKHG7 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| PLEKHG7 | APBB2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PLEKHG7 | DMWD | psi-mi:“MI:0915”(physical association) | 0.560 |
| PLEKHG7 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| PLEKHG7 | FGFR3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GRN | PLEKHG7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GRIN2C | PLEKHG7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PLEKHG7 | GSN | psi-mi:“MI:0915”(physical association) | 0.560 |
| PLEKHG7 | HSPB1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PLEKHG7 | NF2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PRKN | PLEKHG7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PLEKHG7 | PMP22 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PLEKHG7 | PPT1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TSC1 | PLEKHG7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PLEKHG7 | WFS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PLEKHG7 | RAB7A | psi-mi:“MI:0915”(physical association) | 0.560 |
| PLEKHG7 | SPTLC1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PLEKHG7 | CCT5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PLEKHG7 | KIF1B | psi-mi:“MI:0915”(physical association) | 0.560 |
| PLEKHG7 | RNF11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| UBQLN1 | PLEKHG7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PLEKHG7 | SPRED1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SNCA | PLEKHG7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HTT | PLEKHG7 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (23): CORO1B (Proximity Label-MS), PLEKHG7 (Proximity Label-MS), ANKFY1 (Affinity Capture-MS), BYSL (Affinity Capture-MS), CTNND1 (Affinity Capture-MS), DLAT (Affinity Capture-MS), MAGED1 (Affinity Capture-MS), MAT2A (Affinity Capture-MS), MYCBP (Affinity Capture-MS), SF3A1 (Affinity Capture-MS), EIF3G (Affinity Capture-MS), CAPZA2 (Affinity Capture-MS), CIRBP (Affinity Capture-MS), CPSF2 (Affinity Capture-MS), DYRK1B (Affinity Capture-MS)
ESM2 similar proteins: A2A690, A2AWP8, A2RRU4, F1LQY6, F1LTE0, F1LXF1, O88842, O94827, O95267, P11274, P49797, Q0P5I0, Q14161, Q14CM0, Q29RM4, Q3B7L5, Q3UHE1, Q5JSP0, Q5R5M3, Q5R5T1, Q5T6S3, Q5XIS9, Q66H91, Q66T02, Q68FF6, Q6PAJ1, Q6RFZ7, Q6ZN54, Q6ZPY2, Q6ZR37, Q76JQ2, Q7Z6G3, Q80YA9, Q8BZ03, Q8R1S4, Q8TBP0, Q8TCU6, Q8WXI2, Q91ZP9, Q96JH8
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 94 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Assembly and cell surface presentation of NMDA receptors | 7 | 26.5× | 1e-06 |
| Neurexins and neuroligins | 9 | 26.4× | 1e-08 |
| Protein-protein interactions at synapses | 5 | 19.8× | 3e-04 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| protein localization to synapse | 5 | 43.0× | 3e-05 |
| establishment or maintenance of epithelial cell apical/basal polarity | 6 | 39.2× | 4e-06 |
| regulation of postsynaptic membrane neurotransmitter receptor levels | 7 | 39.0× | 4e-07 |
| adult locomotory behavior | 5 | 16.9× | 9e-04 |
| cell-cell adhesion | 8 | 9.1× | 5e-04 |
| protein-containing complex assembly | 6 | 7.7× | 7e-03 |
| negative regulation of neuron apoptotic process | 6 | 7.5× | 7e-03 |
| chemical synaptic transmission | 7 | 6.1× | 7e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
64 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 48 |
| Likely benign | 3 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2450 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:92737478:G:GG | donor_gain | 1.0000 |
| 12:92740849:A:AG | acceptor_gain | 1.0000 |
| 12:92740850:A:G | acceptor_gain | 1.0000 |
| 12:92745592:G:GG | donor_gain | 1.0000 |
| 12:92754088:A:AG | acceptor_gain | 1.0000 |
| 12:92754088:AGT:A | acceptor_gain | 1.0000 |
| 12:92754089:G:GG | acceptor_gain | 1.0000 |
| 12:92754089:GTG:G | acceptor_gain | 1.0000 |
| 12:92754265:G:GG | donor_gain | 1.0000 |
| 12:92754278:A:G | donor_gain | 1.0000 |
| 12:92756283:C:A | acceptor_gain | 1.0000 |
| 12:92756295:AAGT:A | acceptor_gain | 1.0000 |
| 12:92756296:A:G | acceptor_gain | 1.0000 |
| 12:92703101:GC:G | donor_gain | 0.9900 |
| 12:92703128:TACAG:T | donor_loss | 0.9900 |
| 12:92703129:ACAGG:A | donor_loss | 0.9900 |
| 12:92703130:CAG:C | donor_loss | 0.9900 |
| 12:92703131:AGG:A | donor_loss | 0.9900 |
| 12:92703132:GG:G | donor_loss | 0.9900 |
| 12:92703133:G:GA | donor_loss | 0.9900 |
| 12:92706470:GAT:G | acceptor_gain | 0.9900 |
| 12:92736570:GTCT:G | donor_gain | 0.9900 |
| 12:92736571:TCTT:T | donor_gain | 0.9900 |
| 12:92736574:TAAG:T | donor_loss | 0.9900 |
| 12:92736578:GT:G | donor_loss | 0.9900 |
| 12:92737371:T:G | acceptor_gain | 0.9900 |
| 12:92737518:GATG:G | donor_gain | 0.9900 |
| 12:92740851:A:AG | acceptor_gain | 0.9900 |
| 12:92740852:G:GG | acceptor_gain | 0.9900 |
| 12:92741489:A:AG | acceptor_gain | 0.9900 |
AlphaMissense
4507 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 12:92706740:T:C | F37L | 0.986 |
| 12:92706742:T:A | F37L | 0.986 |
| 12:92706742:T:G | F37L | 0.986 |
| 12:92741494:A:C | S35R | 0.977 |
| 12:92741496:C:A | S35R | 0.977 |
| 12:92741496:C:G | S35R | 0.977 |
| 12:92770094:T:A | W347R | 0.970 |
| 12:92770094:T:C | W347R | 0.970 |
| 12:92761800:T:C | L250P | 0.968 |
| 12:92755896:T:A | W188R | 0.966 |
| 12:92755896:T:C | W188R | 0.966 |
| 12:92740922:T:C | F25L | 0.965 |
| 12:92740924:T:A | F25L | 0.965 |
| 12:92740924:T:G | F25L | 0.965 |
| 12:92764129:T:A | V290E | 0.965 |
| 12:92764141:C:A | P294H | 0.957 |
| 12:92764141:C:G | P294R | 0.954 |
| 12:92740930:C:A | N27K | 0.950 |
| 12:92740930:C:G | N27K | 0.950 |
| 12:92761800:T:G | L250R | 0.950 |
| 12:92769010:T:A | I321K | 0.946 |
| 12:92754178:T:C | L135S | 0.945 |
| 12:92706787:G:C | R52S | 0.943 |
| 12:92706787:G:T | R52S | 0.943 |
| 12:92764144:T:A | I295N | 0.943 |
| 12:92761785:T:C | L245P | 0.942 |
| 12:92761806:T:A | V252D | 0.941 |
| 12:92745574:T:C | F100L | 0.937 |
| 12:92745576:T:A | F100L | 0.937 |
| 12:92745576:T:G | F100L | 0.937 |
dbSNP variants (sampled 300 via entrez): RS1000051737 (12:92758365 T>C), RS1000062714 (12:92754425 A>G), RS1000076229 (12:92710379 T>C), RS1000137474 (12:92729791 G>A), RS1000146403 (12:92713876 G>A), RS1000174517 (12:92703401 TAAAG>T), RS1000191553 (12:92710799 T>A,C), RS1000202512 (12:92740114 G>A), RS1000233437 (12:92751981 C>A), RS1000252878 (12:92736667 C>A,T), RS1000258420 (12:92701177 C>G,T), RS1000335032 (12:92748898 G>C), RS1000340126 (12:92765495 G>A,T), RS1000419978 (12:92716302 T>A,G), RS1000478431 (12:92743221 T>C,G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
6 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001102_6 | Sudden cardiac arrest | 5.000000e-06 |
| GCST002127_12 | Periodontitis (Mean PAL) | 7.000000e-06 |
| GCST006193_5 | Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test) | 3.000000e-11 |
| GCST006194_7 | Diastolic blood pressure x smoking status (current vs non-current) interaction (1df test) | 3.000000e-07 |
| GCST006195_90 | Systolic blood pressure x smoking status (current vs non-current) interaction (2df test) | 3.000000e-08 |
| GCST006269_899 | General cognitive ability | 1.000000e-08 |
EFO canonical traits (5, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004278 | sudden cardiac arrest |
| EFO:0006336 | diastolic blood pressure |
| EFO:0006527 | smoking status measurement |
| EFO:0006335 | systolic blood pressure |
| EFO:0004337 | intelligence |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | decreases expression, increases methylation, affects methylation | 2 |
| FR900359 | increases phosphorylation | 1 |
| tebuconazole | decreases expression | 1 |
| abrine | decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Zoledronic Acid | increases expression | 1 |
| N-Nitrosopyrrolidine | decreases expression | 1 |
| Rotenone | increases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.